Life Sciences Master Fund Ltd Perceptive serves as Executive at XTL BIOPHARMACEUTICALS LTD, where they oversee executive responsibilities. Since joining the company, Life Sciences Master Fund Ltd Perceptive has executed 253 insider transactions totaling $631.6M, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 13, 2007 involved selling 780 shares valued at $6.0K.
Life Sciences Master Fund Ltd Perceptive currently holds 5,292,556 shares of XTL BIOPHARMACEUTICALS LTD (XTLB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Life Sciences Master Fund Ltd Perceptive has been a net buyer of XTLB stock. They have purchased $554.3M and sold $77.3M worth of shares.
Life Sciences Master Fund Ltd Perceptive's most recent insider trade was on Dec 13, 2007, when they sold 780 shares at $7.75 per share.
Get notified when new Form 4 filings are submitted
| $7.38 |
| Discretionary |
| Jan 4, 2005 | XTLB | $592.2K | Purchase | 188,000 | $3.15 | Discretionary |